ITGB3 and neoplasm: Recent study has proved that, by mediating the signal of TGF-beta to MAPKs, β3 Integrin (ITGB3) is recognized as the switching molecule during the phenotypic conversion of TGF-beta from a tumor suppressor to a promoter [31].